Harpoon Therapeutics Inc
(HARP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -17,635 | -10,875 | 0 | 0 |
| Depreciation Amortization | 447 | 288 | 0 | 0 |
| Accounts payable and accrued liabilities | -10 | -32 | N/A | N/A |
| Other Working Capital | -3,955 | -3,280 | 0 | 0 |
| Other Operating Activity | 471 | 319 | 0 | 0 |
| Operating Cash Flow | $-20,682 | $-13,580 | $0 | $0 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -506 | -315 | 0 | 0 |
| Investing Cash Flow | $-506 | $-315 | $0 | $0 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 134 | 32 | N/A | N/A |
| Other Financing Activity | 19,956 | 0 | 0 | 0 |
| Financing Cash Flow | $20,090 | $32 | $0 | $0 |
| Beginning Cash Position | 29,423 | 29,423 | 0 | 0 |
| End Cash Position | 28,325 | 15,560 | 0 | 0 |
| Net Cash Flow | $-1,098 | $-13,863 | $0 | $0 |
| Free Cash Flow | ||||
| Operating Cash Flow | -20,682 | -13,580 | 0 | 0 |
| Capital Expenditure | -506 | -315 | N/A | N/A |
| Free Cash Flow | -21,188 | -13,895 | 0 | 0 |